Carcinoma of the tongue: A case series analysis of clinical presentation, risk factors, staging, and outcome

被引:98
|
作者
Gorsky, M
Epstein, JB
Oakley, C
Le, ND
Hay, J
Stevenson-Moore, P
机构
[1] Univ Illinois, Dept Oral Med & Diagnost Sci, Coll Dent, Interdisciplinary Program Oral Canc, Chicago, IL 60020 USA
[2] Univ Illinois, Dept Oral Med & Clin Dent, Coll Dent, Interdisciplinary Program Oral Canc, Chicago, IL 60020 USA
[3] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel
[4] British Columbia Canc Agcy, Div Dent, Vancouver, BC V5Z 4E6, Canada
关键词
D O I
10.1016/j.tripleo.2003.12.041
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. Oral cancer is primarily a disease of epithelial origin. The tongue is the most common site of oral cancer. Oropharyngeal cancer accounts for approximately 2% of all cancer deaths. The purpose of this study was to analyze a case series of patients with tongue cancer. Study design. The medical records of 322 consecutive patients diagnosed with squamous cell carcinoma (SCC) of the tongue treated from 1979-1994 were reviewed. Results. Patients had a mean age of 61.1 years and a 1.5:1 male to female ratio. Approximately, half of the cancers were diagnosed at an advanced stage and most involved the base of the tongue. The majority of oral tongue tumors were diagnosed at an early stage and had more well-differentiated cell types than those of the base of the tongue. Localized discomfort was the most common complaint (66.5%), present for up to 6 months in patients prior to diagnosis and were related to the oral tongue in 90% of cases. Symptoms associated with base of tongue lesions included neck masses, dysphagia, ear pain, and weight loss. Seventy-nine percent of the patients smoked, 58% consumed alcohol on a daily basis, and 43% consumed more than 4 alcoholic drinks daily. Primary radiotherapy was the treatment of 49.6% lesions, of which 57% were at an early stage at diagnosis. The mean overall survival was 3 years and 5 months, with a 5-year overall survival of 40%. Patients with stage 1 tumors had a disease-specific survival of over 80%. The 5-year survival of patients with cancer of the oral tongue was 43% and cancer of the base of the tongue was 27%. Conclusion. The prognosis is poorer for patients presenting with advanced stage and with tumors involving the base of the tongue. Symptoms were more common in tumors of the oral tongue, which likely results in earlier diagnosis. Patients with SCC of the base of the tongue presented with advanced stage of disease and were typically poorly differentiated lesions.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 50 条
  • [41] CASE SERIES OF PROXIMAL ILIAC VEIN OCCLUSION COMPLICATED BY THROMBOSIS RISK FACTORS AND PRESENTATION
    Apostolova, Mariya H.
    DeFilipp, Zachariah
    Prendergast, Lori
    Thurlow, Peter
    Kennedy, Margaret
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E32 - E32
  • [42] Tongue Metastasis From Renal Cell Carcinoma: A Rare Case Presentation
    Kweon, Hyeok Tae
    Yoo, Ji Seob
    Hong, Yong Tae
    ENT-EAR NOSE & THROAT JOURNAL, 2024,
  • [43] Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis (PSC) - A case control study.
    Bergqvist, A
    Broome, U
    HEPATOLOGY, 1996, 24 (04) : 175 - 175
  • [44] Cancer of the tongue: Comparing outcome in patients with no known risk factors with those with high risk factors
    Hod, R.
    Irish, J.
    Goldstein, D.
    Brown, D.
    Bachar, G.
    Shpitzer, T.
    ORAL ONCOLOGY, 2009, : 76 - 76
  • [45] CLINICAL FEATURES AND OUTCOME OF HEPATOCELLULAR CARCINOMA PATIENTS WITHOUT ETIOLOGIC RISK FACTORS
    Shiba, S.
    Kondo, S.
    Morizane, C.
    Ueno, H.
    Hayashi, H.
    Sakamoto, Y.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2013, 24 : 41 - 41
  • [46] Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis
    Ono, Sawako
    Hirose, Katsutoshi
    Sukegawa, Shintaro
    Obata, Kyoichi
    Masui, Masanori
    Hasegawa, Kazuaki
    Fujimura, Ai
    Shimada, Katsumitsu
    Nakamura, Satoko
    Teramoto, Akari
    Hori, Yumiko
    Morii, Eiichi
    Motooka, Daisuke
    Igawa, Takuro
    Tanaka, Takehiro
    Nagatsuka, Hitoshi
    Toyosawa, Satoru
    Yamamoto, Hidetaka
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [47] Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation
    Filgueira, Norma Arteiro
    WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (03) : 261 - 272
  • [48] Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation
    Norma Arteiro Filgueira
    World Journal of Hepatology, 2019, (03) : 261 - 272
  • [49] Clinical Presentation, Approach and Outcome of Gliosarcoma: A Series of 12 Cases
    Singh, Shreya
    Mishra, Ritusha
    Naik, Bitan
    Shah, Manav
    Mishra, Himanshu
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (03) : XR1 - XR3
  • [50] Clinical presentation and outcome in a series of 88 patients with the cblC defect
    Fischer, Sabine
    Huemer, Martina
    Baumgartner, Matthias
    Deodato, Federica
    Ballhausen, Diana
    Boneh, Avihu
    Burlina, Alberto B.
    Cerone, Roberto
    Garcia, Paula
    Goekcay, Guelden
    Gruenewald, Stephanie
    Haeberle, Johannes
    Jaeken, Jaak
    Ketteridge, David
    Lindner, Martin
    Mandel, Hanna
    Martinelli, Diego
    Martins, Esmeralda G.
    Schwab, Karl O.
    Gruenert, Sarah C.
    Schwahn, Bernd C.
    Sztriha, Laszlo
    Tomaske, Maren
    Trefz, Friedrich
    Vilarinho, Laura
    Rosenblatt, David S.
    Fowler, Brian
    Dionisi-Vici, Carlo
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (05) : 831 - 840